Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors

Journal of Nuclear Medicine

Volumn 51, Issue 9, 2010, Pages 1386-1394

  Shi, Kuangyu ^a   Souvatzoglou, Michael ^a   Astner, Sabrina T ^a   Vaupel, Peter ^a   Nüsslin, Fridtjof ^a   Wilkens, Jan J ^a   Ziegler, Sibylle I ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Head and neck tumor; Kinetic modeling; PET; Tumor hypoxia; Tumor perfusion

Indexed keywords

FLUOROAZOMYCIN ARABINOSIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WATER O 15; DIAGNOSTIC AGENT; FLUOROAZOMYCIN ARABINOSIDE; NITROIMIDAZOLE DERIVATIVE; OXYGEN; WATER;

ACCURACY; ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOXIA; HYPOXIA KINETIC MODEL; KINETICS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME; BIOLOGICAL MODEL; CELL HYPOXIA; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; VASCULARIZATION;

ADULT; CELL HYPOXIA; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITROIMIDAZOLES; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; WATER;

EID: 77957088726     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.074336     Document Type: Article

References (39)

1. Huang SC, Phelps ME. Principles of tracer kinetic modeling in positron emission tomography and autoradiography. In: Phelps ME, Mazziotta J, Schelbert HR, eds. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. New York, NY: Raven Press; 1986:287-346.
2. Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21:635-652. (Pubitemid 32510452)
3. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158. (Pubitemid 27024284)
4. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
5. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
6. 13N-ammonia and PET: comparison of tracer models. J Nucl Med. 1999;40:1045-1055.
7. 11C[rsqb](R)-PK11195 studies. J Cereb Blood Flow Metab. 2006;26:1431-1441.
8. Feng D, Ho D, Chen K, et al. An evaluation of the algorithms for determining local cerebral metabolic rates of glucose using positron emission tomography dynamic data. IEEE Trans Med Imaging. 1995;14:697-710.
9. Yaqub M, Boellaard R, Kropholler MA, Lammertsma AA. Optimization algorithms and weighting factors for analysis of dynamic PET studies. Phys Med Biol. 2006;51:4217-4232.
10. Wang W, Georgi JC, Nehmeh SA, et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol. 2009;54:3083-3099.
11. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49:6449-6465.
12. 2 tension measurements. Cancer Res. 1991;51:3316-3322.
13. Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur Radiol. 2007;17:861-872.
14. 18FFluoromisonidazole. Int J Radiat Oncol Biol Phys. 1992;22:199-212.
15. 18F-fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 1996;36:417-428.
16. Lehtio K, Eskola O, Viljanen T, et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;59:971-982.
17. Lewis JS, Herrero P, Sharp TL, et al. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2002;43:1557-1569.
18. 18F-fluoroazomycin arabinoside. J Nucl Med. 2005;46:106-113.
19. 18F-FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging. 2007;34:1566-1575.
20. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583-592.
21. 18FFmiso PET data to analyse tumour hypoxia. Phys Med Biol. 2005;50:2209-2224.
22. 18F-fluoromisonidazole PET time-activity data. Med Phys. 1995;22:1127-1139.
23. Cho H, Ackerstaff E, Carlin S, et al. Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. Neoplasia. 2009;11:247-259.
24. 2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys. 2008;70:1202-1212.
25. Carlin S, Pugachev A, Sun X, et al. In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression. Nucl Med Biol. 2009;36:821-831.
26. 18F-fluoroerythronitroimidazole PET. J Nucl Med. 2001;42:1643-1652.
27. 2O. J Nucl Med. 2004;45:1851-1859.
28. Iida H, Miura S, Shoji Y, et al. Noninvasive quantitation of cerebral blood flow using oxygen-15-water and a dual-PET system. J Nucl Med. 1998;39:1789-1798.
29. Feng D, Huang SC, Wang X. Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int J Biomed Comput. 1993;32:95-110. (Pubitemid 23090835)
30. 15O-labeled water and PET. J Nucl Med. 2008;49:1763-1768.
31. Bruehlmeier M, Kaser-Hotz B, Achermann R, et al. Measurement of tumor hypoxia in spontaneous canine sarcomas. Vet Radiol Ultrasound. 2005;46:348-354. (Pubitemid 41413580)
32. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266-276.
33. Vaupel P, Höckel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007;9:1221-1236.
34. 18F-FMISO PET. Med Phys. 2009;36:4400-4408.
35. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 1996;56:5522-5528.
36. Vaupel P. Pathophysiology of solid tumors. In: Molls M, Vaupel P, Nieder C, Anscher MS, eds. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. Berlin, Heidelberg, Germany: Springer; 2009:51-92.
37. Vaupel P. Physiological mechanisms of treatment resistance. In: Molls M, Vaupel P, Nieder C, Anscher MS, eds. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. Berlin, Heidelberg, Germany: Springer; 2009:273-290.
38. Thews G, Mutschler E, Vaupel P. Anatomie, Physiologie, Pathophysiologie des Menschen. 6th ed. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft; 2007.
39. Ruotsalainen U, Raitakari M, Nuutila P, et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med. 1997;38:314-319.